Written Question·Department of Health and Social Care·UIN 35581
Obesity: Drugs
Tabled: 4 March 2025
Answered: 10 March 2025
Question
Helen Maguire
Liberal Democrat — Epsom and Ewell
To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on expanding the list of weight-related comorbidities on their tirzepatide guidance to include polycystic ovarian syndrome.
Answer
Karin SmythThe National Institute for Health and Care Excellence (NICE) has published technology appraisal guidance that recommends tirzepatide to treat obesity, alongside a reduced calorie-diet and increased physical activity, in adults with a body mass index of 35...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 35581) →